Zobrazeno 1 - 10
of 24
pro vyhledávání: '"T. Michael Numnum"'
Autor:
Kimberly A. Shipman, J. Michael Straughn, Jenny M. Whitworth, T. Michael Numnum, Larry C. Kilgore, Kellie S. Matthews, James E. Kendrick
Publikováno v:
Gynecologic Oncology. 112:601-604
Objective Pegfilgrastim is indicated to decrease the incidence of febrile neutropenia in patients with gynecologic malignancies who are receiving myelosuppressive chemotherapy. We sought to compare the safety and efficacy of day 1 pegfilgrastim admin
Autor:
Jacob M. Estes, J. Michael Straughn, Kristopher J. Kimball, Charles A. Leath, James E. Kendrick, T. Michael Numnum
Publikováno v:
Journal of the American College of Surgeons. 207:393-397
Background To develop a standardized protocol for management of postoperative fever in gynecology patients to decrease unnecessary diagnostic workups and empiric use of antibiotics. Study Design A prospective analysis of postoperative gynecology pati
A Prospective Evaluation of a Simulator-Based Laparoscopic Training Program for Gynecology Residents
Publikováno v:
Journal of the American College of Surgeons. 206:343-348
To determine prospectively if simulator-based laparoscopic training could improve laparoscopic skills of gynecology residents.Twenty-six gynecology residents were enrolled in a laparoscopy training curriculum involving didactics, self-paced learning
Autor:
Amanda S Moon, Louise T. Chow, David T. Curiel, Mariam A. Stoff-Khalili, Peter Dall, Larissa Pereboeva, Rodney P. Rocconi, Gene P. Siegal, J. Michael Mathis, Hans Georg Bender, N. Sanjib Banerjee, Zeng B. Zhu, Alexander Stoff, Angel A. Rivera, Joanne T. Douglas, Alexandra P. Hess, Maaike Everts, T. Michael Numnum
Publikováno v:
Breast Cancer Research and Treatment. 105:157-167
Alternative and complementary therapeutic strategies need to be developed for metastatic breast cancer. Virotherapy is a novel therapeutic approach for the treatment of cancer in which the replicating virus itself is the anticancer agent. However, th
Publikováno v:
Current Oncology Reports. 8:441-447
Ovarian cancer remains the leading cause of death due to gynecologic cancer in women in the United States. Gene and viral-based therapies represent novel therapeutic approaches for cancer. The manipulation of genetic content of tumor cells toward a t
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma
Publikováno v:
Gynecologic Oncology. 102:425-428
Objective To evaluate our experience with the use of bevacizumab in patients with heavily pretreated recurrent ovarian carcinoma who have symptomatic ascites. Methods Four patients were identified who were previously heavily pretreated for recurrent
Autor:
Maurie Markman, Thomas W. Burke, T. Michael Numnum, Larry C. Kilgore, Gillian Thomas, J. Michael Straughn, Edward E. Partridge, Jerri Linn Phillips
Publikováno v:
Gynecologic Oncology. 99:530-535
Objective. To determine the outcomes of patients with intermediate-risk Stages IC and II uterine corpus cancer treated with surgery alone or surgery followed by radiation therapy. Methods. Patients with uterine corpus cancer diagnosed in 1995 were id
Autor:
Mariam A. Stoff-Khalili, T. Michael Numnum, Rodney P. Rocconi, Ronald D. Alvarez, David T. Curiel, Sharmila K. Makhija
Publikováno v:
Current Gene Therapy. 5:643-653
Despite advances in therapy, advanced ovarian cancer maintains a dismal overall survival of 15-30%. Thus, the need for novel therapeutic modalities exists. Gene therapy represents one such approach and the purpose of this review is to present a logic
Autor:
J. Michael Straughn, Wiley L. Fowler, Tyler O. Kirby, Rodney P. Rocconi, Jason D. Wright, Snehal M. Bhoola, Warner K. Huh, James E. Kendrick, T. Michael Numnum, David G. Mutch
Publikováno v:
Gynecologic Oncology. 98:309-312
Objectives. To investigate the patterns of recurrence associated with superficial inguinal lymphadenectomy (SupIL) and vulvectomy for patients with Stage I/II vulvar cancer. Methods. A retrospective chart review identified patients from 1990–2001 w
Autor:
Marc J. Kleinberg, J.Maxwell Austin, J. Michael Straughn, Charles A. Leath, Seng Jaw Soong, Yuting Zhang, Larry C. Kilgore, Johnny Hyde, Edward E. Partridge, Warner K. Huh, Ronald D. Alvarez, F. Joseph Kelly, T. Michael Numnum
Publikováno v:
Gynecologic Oncology. 84:194-200
Objective. The aim of this study was to determine the outcomes of Stage I endometrial carcinoma patients who are managed without adjuvant radiation after comprehensive surgical staging. Methods. A computerized hospital database identified women diagn